Virtus LifeSci Performance

BBC -- USA Etf  

USD 33.07  0.86  2.53%

The entity has beta of -0.7668 which indicates as returns on market increase, returns on owning Virtus LifeSci are expected to decrease at a much smaller rate. During bear market, Virtus LifeSci is likely to outperform the market.. Although it is vital to follow to Virtus LifeSci Biotech current price movements, it is good to be conservative about what you can actually do with the information regarding equity historical returns. The philosophy towards measuring future performance of any etf is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By inspecting Virtus LifeSci Biotech technical indicators you can presently evaluate if the expected return of 0.2702% will be sustainable into the future.
Horizon     30 Days    Login   to change

Virtus LifeSci Biotech Relative Risk vs. Return Landscape

If you would invest  3,212  in Virtus LifeSci Biotech Clinical Trls ETF on August 20, 2018 and sell it today you would earn a total of  189.24  from holding Virtus LifeSci Biotech Clinical Trls ETF or generate 5.89% return on investment over 30 days. Virtus LifeSci Biotech Clinical Trls ETF is generating 0.2702% of daily returns assuming volatility of 1.4228% on return distribution over 30 days investment horizon. In other words, 12% of equities are less volatile than the company and above 95% of equities are expected to generate higher returns over the next 30 days.
 Daily Expected Return (%) 
      Risk (%) 
Considering 30-days investment horizon, Virtus LifeSci Biotech Clinical Trls ETF is expected to generate 3.66 times more return on investment than the market. However, the company is 3.66 times more volatile than its market benchmark. It trades about 0.19 of its potential returns per unit of risk. The DOW is currently generating roughly 0.23 per unit of risk.

Virtus LifeSci Market Risk Analysis

Sharpe Ratio = 0.1899
Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small ReturnsBBC
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative Returns

Virtus LifeSci Relative Performance Indicators

Estimated Market Risk
 1.42
  actual daily
 
 88 %
of total potential
  
Expected Return
 0.27
  actual daily
 
 5 %
of total potential
  
Risk-Adjusted Return
 0.19
  actual daily
 
 12 %
of total potential
  
Based on monthly moving average Virtus LifeSci is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Virtus LifeSci by adding it to a well-diversified portfolio.

Virtus LifeSci Performance Rating

Virtus LifeSci Biotech Clinical Trls ETF Risk Adjusted Performance Analysis

12 

Risk-Adjusted Performance

Compared to the overall equity markets, risk-adjusted returns on investments in Virtus LifeSci Biotech Clinical Trls ETF are ranked lower than 12 (%) of all global equities and portfolios over the last 30 days.

Virtus LifeSci Alerts

Equity Alerts and Improvement Suggestions

The fund generated three year return of -1.0%
Virtus LifeSci Biotech Clinical Trls ETF holds 99.71% of its assets under management (AUM) in equities

Virtus LifeSci Dividends

Virtus LifeSci Biotech Dividends Analysis

Check Virtus LifeSci Biotech dividend payout schedule and payment analysis over time. Analyze past dividends calendar and estimate annual dividend income
Check Dividends  
Check also Trending Equities. Please also try Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Search macroaxis.com